Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity

A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 2018-03, Vol.168, p.115-127
Hauptverfasser: Nakano, Ayuki, Asano, Daiki, Kondo, Ryo, Mori, Asami, Arima, Shiho, Ushikubo, Hiroko, Sakamoto, Kenji, Nagamitsu, Tohru, Ishii, Kunio, Nakahara, Tsutomu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 127
container_issue
container_start_page 115
container_title Experimental eye research
container_volume 168
creator Nakano, Ayuki
Asano, Daiki
Kondo, Ryo
Mori, Asami
Arima, Shiho
Ushikubo, Hiroko
Sakamoto, Kenji
Nagamitsu, Tohru
Ishii, Kunio
Nakahara, Tsutomu
description A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10 mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. To induce excitotoxic loss of retinal neurons, N-methyl-D-aspartic acid (NMDA) was injected into the vitreous chamber of the eye on P9. Changes in retinal morphology, blood vessels, and proliferative status of vascular cells were evaluated on P11 and P14. The number of cells in the ganglion cell layer and the thickness of the inner plexiform layer and inner nuclear layer were significantly decreased 2 days (P11) after NMDA treatment. The pattern and degree of NMDA-induced changes in retinal morphology were similar between vehicle-treated (control) and KRN633-treated (ROP) rats. In ROP rats, increases in the density of capillaries, the tortuosity index of arteries, and the proliferating vascular cells were observed on P14. The expansion of the endothelial cell network was prevented, and the capillary density and the number of proliferating cells were reduced in NMDA-treated retinas of both control and ROP rats. Following NMDA-induced neuronal cell loss, no ROP-like blood vessels were observed in the retinas. These results suggest that retinal neurons play an important role in the formation of normal and ROP-like retinal blood vessels. •Short-term VEGF inhibition interrupts retinal vascular development in rats.•The impaired vascular development induces retinal hypoxia and VEGF expression.•The enhanced VEGF-VEGFR2 pathway induces abnormal vascular formation.•Excitotoxic loss of retinal neurons prevents abnormal vascular formation.•Retinal neurons play an important role in abnormal retinal vascular formation.
doi_str_mv 10.1016/j.exer.2017.12.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1989591543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483517301227</els_id><sourcerecordid>1989591543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-73dcbfb11c3fc090b12300cef538d481e723fb3d28f02f9aabe329af610362a3</originalsourceid><addsrcrecordid>eNp9kE9r3DAQxUVJaTZpv0APQcdc7I4k_xPkEkLaFAKFkruQ5VGjxbY2krzpfvvK7DbHnGZG-r0H7xHylUHJgDXftiX-xVByYG3JeAnQfiAbBrIpIO9nZAPAqqLqRH1OLmLc5ldRtdUncs6lEBK6bkNefmNysx7pjEvw62JwHOnoY6S7gHucU6S6n32Y8l84wXsdzTLqQP8E_5qeqZuppkEnOvkBR-rtkfQ7nZ4P65mtJp2W4NLhM_lo9Rjxy2lekqfv9093D8Xjrx8_724fCyPqJhWtGExve8aMsAYk9IwLAIO2Ft1QdQxbLmwvBt5Z4FZq3aPgUtuGgWi4Fpfk-mi7C_5lwZjU5OKaTc_ol6iY7GQtWV2JjPIjakKOHdCqXXCTDgfFQK1Nq61am1Zr04pxldvNoquT_9JPOLxJ_lebgZsjgDnk3mV5NA5ng4MLaJIavHvP_x9M5JID</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989591543</pqid></control><display><type>article</type><title>Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Nakano, Ayuki ; Asano, Daiki ; Kondo, Ryo ; Mori, Asami ; Arima, Shiho ; Ushikubo, Hiroko ; Sakamoto, Kenji ; Nagamitsu, Tohru ; Ishii, Kunio ; Nakahara, Tsutomu</creator><creatorcontrib>Nakano, Ayuki ; Asano, Daiki ; Kondo, Ryo ; Mori, Asami ; Arima, Shiho ; Ushikubo, Hiroko ; Sakamoto, Kenji ; Nagamitsu, Tohru ; Ishii, Kunio ; Nakahara, Tsutomu</creatorcontrib><description>A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10 mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. To induce excitotoxic loss of retinal neurons, N-methyl-D-aspartic acid (NMDA) was injected into the vitreous chamber of the eye on P9. Changes in retinal morphology, blood vessels, and proliferative status of vascular cells were evaluated on P11 and P14. The number of cells in the ganglion cell layer and the thickness of the inner plexiform layer and inner nuclear layer were significantly decreased 2 days (P11) after NMDA treatment. The pattern and degree of NMDA-induced changes in retinal morphology were similar between vehicle-treated (control) and KRN633-treated (ROP) rats. In ROP rats, increases in the density of capillaries, the tortuosity index of arteries, and the proliferating vascular cells were observed on P14. The expansion of the endothelial cell network was prevented, and the capillary density and the number of proliferating cells were reduced in NMDA-treated retinas of both control and ROP rats. Following NMDA-induced neuronal cell loss, no ROP-like blood vessels were observed in the retinas. These results suggest that retinal neurons play an important role in the formation of normal and ROP-like retinal blood vessels. •Short-term VEGF inhibition interrupts retinal vascular development in rats.•The impaired vascular development induces retinal hypoxia and VEGF expression.•The enhanced VEGF-VEGFR2 pathway induces abnormal vascular formation.•Excitotoxic loss of retinal neurons prevents abnormal vascular formation.•Retinal neurons play an important role in abnormal retinal vascular formation.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2017.12.007</identifier><identifier>PMID: 29339088</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Abnormal retinal vascular growth ; Animals ; Capillaries - pathology ; Cell Proliferation - drug effects ; Disease Models, Animal ; N-Methylaspartate - pharmacology ; Phenylurea Compounds - pharmacology ; Protein Kinase Inhibitors - pharmacology ; Quinazolines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Retina - metabolism ; Retina - pathology ; Retinal ganglion cells ; Retinal Ganglion Cells - pathology ; Retinal Neurons - pathology ; Retinal Vessels - pathology ; Retinopathy of prematurity ; Retinopathy of Prematurity - pathology ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors ; Vascular Endothelial Growth Factor A - metabolism ; Vascular endothelial growth factor receptor tyrosine kinase inhibitor</subject><ispartof>Experimental eye research, 2018-03, Vol.168, p.115-127</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-73dcbfb11c3fc090b12300cef538d481e723fb3d28f02f9aabe329af610362a3</citedby><cites>FETCH-LOGICAL-c356t-73dcbfb11c3fc090b12300cef538d481e723fb3d28f02f9aabe329af610362a3</cites><orcidid>0000-0003-1326-6580 ; 0000-0002-3215-1570</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.exer.2017.12.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29339088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakano, Ayuki</creatorcontrib><creatorcontrib>Asano, Daiki</creatorcontrib><creatorcontrib>Kondo, Ryo</creatorcontrib><creatorcontrib>Mori, Asami</creatorcontrib><creatorcontrib>Arima, Shiho</creatorcontrib><creatorcontrib>Ushikubo, Hiroko</creatorcontrib><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Nagamitsu, Tohru</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><title>Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10 mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. To induce excitotoxic loss of retinal neurons, N-methyl-D-aspartic acid (NMDA) was injected into the vitreous chamber of the eye on P9. Changes in retinal morphology, blood vessels, and proliferative status of vascular cells were evaluated on P11 and P14. The number of cells in the ganglion cell layer and the thickness of the inner plexiform layer and inner nuclear layer were significantly decreased 2 days (P11) after NMDA treatment. The pattern and degree of NMDA-induced changes in retinal morphology were similar between vehicle-treated (control) and KRN633-treated (ROP) rats. In ROP rats, increases in the density of capillaries, the tortuosity index of arteries, and the proliferating vascular cells were observed on P14. The expansion of the endothelial cell network was prevented, and the capillary density and the number of proliferating cells were reduced in NMDA-treated retinas of both control and ROP rats. Following NMDA-induced neuronal cell loss, no ROP-like blood vessels were observed in the retinas. These results suggest that retinal neurons play an important role in the formation of normal and ROP-like retinal blood vessels. •Short-term VEGF inhibition interrupts retinal vascular development in rats.•The impaired vascular development induces retinal hypoxia and VEGF expression.•The enhanced VEGF-VEGFR2 pathway induces abnormal vascular formation.•Excitotoxic loss of retinal neurons prevents abnormal vascular formation.•Retinal neurons play an important role in abnormal retinal vascular formation.</description><subject>Abnormal retinal vascular growth</subject><subject>Animals</subject><subject>Capillaries - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>Disease Models, Animal</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Phenylurea Compounds - pharmacology</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Quinazolines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Retina - metabolism</subject><subject>Retina - pathology</subject><subject>Retinal ganglion cells</subject><subject>Retinal Ganglion Cells - pathology</subject><subject>Retinal Neurons - pathology</subject><subject>Retinal Vessels - pathology</subject><subject>Retinopathy of prematurity</subject><subject>Retinopathy of Prematurity - pathology</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vascular endothelial growth factor receptor tyrosine kinase inhibitor</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9r3DAQxUVJaTZpv0APQcdc7I4k_xPkEkLaFAKFkruQ5VGjxbY2krzpfvvK7DbHnGZG-r0H7xHylUHJgDXftiX-xVByYG3JeAnQfiAbBrIpIO9nZAPAqqLqRH1OLmLc5ldRtdUncs6lEBK6bkNefmNysx7pjEvw62JwHOnoY6S7gHucU6S6n32Y8l84wXsdzTLqQP8E_5qeqZuppkEnOvkBR-rtkfQ7nZ4P65mtJp2W4NLhM_lo9Rjxy2lekqfv9093D8Xjrx8_724fCyPqJhWtGExve8aMsAYk9IwLAIO2Ft1QdQxbLmwvBt5Z4FZq3aPgUtuGgWi4Fpfk-mi7C_5lwZjU5OKaTc_ol6iY7GQtWV2JjPIjakKOHdCqXXCTDgfFQK1Nq61am1Zr04pxldvNoquT_9JPOLxJ_lebgZsjgDnk3mV5NA5ng4MLaJIavHvP_x9M5JID</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Nakano, Ayuki</creator><creator>Asano, Daiki</creator><creator>Kondo, Ryo</creator><creator>Mori, Asami</creator><creator>Arima, Shiho</creator><creator>Ushikubo, Hiroko</creator><creator>Sakamoto, Kenji</creator><creator>Nagamitsu, Tohru</creator><creator>Ishii, Kunio</creator><creator>Nakahara, Tsutomu</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1326-6580</orcidid><orcidid>https://orcid.org/0000-0002-3215-1570</orcidid></search><sort><creationdate>201803</creationdate><title>Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity</title><author>Nakano, Ayuki ; Asano, Daiki ; Kondo, Ryo ; Mori, Asami ; Arima, Shiho ; Ushikubo, Hiroko ; Sakamoto, Kenji ; Nagamitsu, Tohru ; Ishii, Kunio ; Nakahara, Tsutomu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-73dcbfb11c3fc090b12300cef538d481e723fb3d28f02f9aabe329af610362a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abnormal retinal vascular growth</topic><topic>Animals</topic><topic>Capillaries - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>Disease Models, Animal</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Phenylurea Compounds - pharmacology</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Quinazolines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Retina - metabolism</topic><topic>Retina - pathology</topic><topic>Retinal ganglion cells</topic><topic>Retinal Ganglion Cells - pathology</topic><topic>Retinal Neurons - pathology</topic><topic>Retinal Vessels - pathology</topic><topic>Retinopathy of prematurity</topic><topic>Retinopathy of Prematurity - pathology</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vascular endothelial growth factor receptor tyrosine kinase inhibitor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakano, Ayuki</creatorcontrib><creatorcontrib>Asano, Daiki</creatorcontrib><creatorcontrib>Kondo, Ryo</creatorcontrib><creatorcontrib>Mori, Asami</creatorcontrib><creatorcontrib>Arima, Shiho</creatorcontrib><creatorcontrib>Ushikubo, Hiroko</creatorcontrib><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Nagamitsu, Tohru</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakano, Ayuki</au><au>Asano, Daiki</au><au>Kondo, Ryo</au><au>Mori, Asami</au><au>Arima, Shiho</au><au>Ushikubo, Hiroko</au><au>Sakamoto, Kenji</au><au>Nagamitsu, Tohru</au><au>Ishii, Kunio</au><au>Nakahara, Tsutomu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2018-03</date><risdate>2018</risdate><volume>168</volume><spage>115</spage><epage>127</epage><pages>115-127</pages><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10 mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. To induce excitotoxic loss of retinal neurons, N-methyl-D-aspartic acid (NMDA) was injected into the vitreous chamber of the eye on P9. Changes in retinal morphology, blood vessels, and proliferative status of vascular cells were evaluated on P11 and P14. The number of cells in the ganglion cell layer and the thickness of the inner plexiform layer and inner nuclear layer were significantly decreased 2 days (P11) after NMDA treatment. The pattern and degree of NMDA-induced changes in retinal morphology were similar between vehicle-treated (control) and KRN633-treated (ROP) rats. In ROP rats, increases in the density of capillaries, the tortuosity index of arteries, and the proliferating vascular cells were observed on P14. The expansion of the endothelial cell network was prevented, and the capillary density and the number of proliferating cells were reduced in NMDA-treated retinas of both control and ROP rats. Following NMDA-induced neuronal cell loss, no ROP-like blood vessels were observed in the retinas. These results suggest that retinal neurons play an important role in the formation of normal and ROP-like retinal blood vessels. •Short-term VEGF inhibition interrupts retinal vascular development in rats.•The impaired vascular development induces retinal hypoxia and VEGF expression.•The enhanced VEGF-VEGFR2 pathway induces abnormal vascular formation.•Excitotoxic loss of retinal neurons prevents abnormal vascular formation.•Retinal neurons play an important role in abnormal retinal vascular formation.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29339088</pmid><doi>10.1016/j.exer.2017.12.007</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-1326-6580</orcidid><orcidid>https://orcid.org/0000-0002-3215-1570</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2018-03, Vol.168, p.115-127
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_1989591543
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Abnormal retinal vascular growth
Animals
Capillaries - pathology
Cell Proliferation - drug effects
Disease Models, Animal
N-Methylaspartate - pharmacology
Phenylurea Compounds - pharmacology
Protein Kinase Inhibitors - pharmacology
Quinazolines - pharmacology
Rats
Rats, Sprague-Dawley
Retina - metabolism
Retina - pathology
Retinal ganglion cells
Retinal Ganglion Cells - pathology
Retinal Neurons - pathology
Retinal Vessels - pathology
Retinopathy of prematurity
Retinopathy of Prematurity - pathology
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Vascular Endothelial Growth Factor A - metabolism
Vascular endothelial growth factor receptor tyrosine kinase inhibitor
title Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T04%3A44%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinal%20neuronal%20cell%20loss%20prevents%20abnormal%20retinal%20vascular%20growth%20in%20a%20rat%20model%20of%20retinopathy%20of%20prematurity&rft.jtitle=Experimental%20eye%20research&rft.au=Nakano,%20Ayuki&rft.date=2018-03&rft.volume=168&rft.spage=115&rft.epage=127&rft.pages=115-127&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2017.12.007&rft_dat=%3Cproquest_cross%3E1989591543%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1989591543&rft_id=info:pmid/29339088&rft_els_id=S0014483517301227&rfr_iscdi=true